Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis.
| Last: | $9.14 |
|---|---|
| Change Percent: | -3.23% |
| Open: | $9.12 |
| Close: | $9.445 |
| High: | $9.3299 |
| Low: | $9.07 |
| Volume: | 147,847 |
| Last Trade Date Time: | 02/27/2026 12:44:45 pm |
| Market Cap: | $980,578,221 |
|---|---|
| Float: | 54,762,130 |
| Insiders Ownership: | 4.62% |
| Institutions: | 62 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.ars-pharma.com |
| Country: | US |
| City: | San Diego |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about ARS Pharmaceuticals Inc. (NASDAQ: SPRY).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
